---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-071345"
form_type: "8-K"
ticker: "BEAM"
cik: "0001745999"
company_name: "Beam Therapeutics Inc."
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:20:33.035585+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Beam Therapeutics shareholders elect Graham Cooper as Class I director, ratify auditor, approve say-on-pay

## Summary
- Graham Cooper elected to board with 49.5M for, 6.5M against, 1.8M abstain, 8.4M broker non-votes.
- Deloitte & Touche ratified as auditor for FY2024: 66.0M for, 176k against, 42k abstain.
- Advisory vote on executive compensation passed: 56.5M for, 1.3M against, 45k abstain, 8.4M broker non-votes.

## SEC filing metadata
- accession: 0000950170-24-071345
- form_type: 8-K
- ticker: BEAM
- cik: 0001745999
- company_name: Beam Therapeutics Inc.
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1745999/000095017024071345/0000950170-24-071345-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1745999/000095017024071345/beam-20240605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-071345
- JSON: https://secwatch.observer/filing/0000950170-24-071345.json
- Plain text: https://secwatch.observer/filing/0000950170-24-071345.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.